CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Counteracting Interleukin-15 to Elucidate Its Modes of Action in Physiology and Pathology.
Counteracting Interleukin-15 to Elucidate Its Modes of Action in Physiology and Pathology.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
白细胞介素(IL)-15与IL-2、IL-4、IL-7、IL-9和IL-21同属于共同γ链依赖性细胞因子家族。IL-15对自然杀伤(NK)细胞和记忆CD8 T细胞的稳态以及对抗癌症进展至关重要。然而,IL-15表达的失调可能发生,并参与自身免疫性炎症疾病以及血液系统恶性肿瘤的发生。因此,了解IL-15的不同作用模式非常重要,以便在不影响其在免疫系统中有益作用的情况下减少其在病理中的有害作用。在这篇综述中,我们介绍了研究人员用于抑制IL-15作用的不同方法,从最广泛到最具选择性。事实上,似乎重要的是选择性地靶向该细胞因子的作用模式而非细胞因子本身,因为它们参与众多生物过程。
Interleukin (IL)-15 belongs to the common gamma-dependent cytokine family, along with IL-2, IL-4, IL-7, IL-9, and IL-21. IL-15 is crucial for the homeostasis of Natural Killer (NK) and memory CD8 T cells, and to fight against cancer progression.
However, dysregulations of IL-15 expression could occur and participate in the emergence of autoimmune inflammatory diseases as well as hematological malignancies. It is therefore important to understand the different modes of action of IL-15 to decrease its harmful action in pathology without affecting its beneficial effects in the immune system.
In this review, we present the different approaches used by researchers to inhibit the action of IL-15, from most broad to the most selective. Indeed, it appears that it is important to selectively target the mode of action of the cytokine rather than the cytokine itself as they are involved in numerous biological processes.
MEMBER ACCOUNT
登录成功会直接打开下一页。